Delivery Order SPE2DB22D1106-SPE2DB25FFAU9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Icosapent Ethyl 1 gram capsules (120-count) with a ceiling value of $14,335.03. This firm fixed-price delivery order, which is not set-aside designated, is scheduled for ultimate completion on July 29, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Icosapent ethyl is a prescription medication used for cardiovascular health...
- The Defense Logistics Agency awarded a delivery order valued at $1,281.58 to AmerisourceBergen Drug Corp for Icosapent Ethyl 1 gram capsules (120-count package), with an ultimate completion date of July 28, 2025. This non-competitive, competitively awarded delivery order represents a firm fixed price procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing this work at...
- This is a $1,037.55 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a pharmaceutical product. The order has a firm fixed price and an ultimate completion date of August 1, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
- The Defense Logistics Agency awarded a $783.68 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 capsules of 1 gram Icosapent Ethyl capsules. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania by August 8, 2023 under the terms of the contract. No subcontractors or set aside designations were identified. The Defense Logistics Agency supports United States military services...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical. The $1,186 delivery order is to supply 120 capsules of 1 gram Icosapent Ethyl to support DLA medical facilities. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by December 13, 2023. No set aside designation was applied...
- The Defense Logistics Agency awarded a $9,269 delivery order to Amerisourcebergen Drug Corporation for 120 capsules of 1 gram Icosapent Ethyl capsules to be delivered to a location in Conshohocken, Pennsylvania. The firm fixed price order is valued at approximately $9,269 and will be fulfilled between September 13-14, 2023. The prime contractor, Amerisourcebergen Drug Corporation, will deliver the requested pharmaceutical products to the Defense Logistics Agency facility in Pennsylvania in...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a pharmaceutical product. The contract has a ceiling value of $1,302.16 and a period of performance extending through June 25, 2025. This award is not set aside and represents an open competition. AmerisourceBergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,374.04 firm fixed-price delivery order is for the supply of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of November 28, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,420.97 firm-fixed-price delivery order is for the supply of Icosapent Ethyl 1 gram capsules, a cardiovascular medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This federal contract award is for the delivery of 120 count 1 gram capsules of Icosapent Ethyl, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $1,132.46, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 7, 2023. The contract has a final completion date of November 8, 2023 and is structured as a firm fixed-price delivery order. No set-aside designations were used for this award. Amerisourcebergen Drug Corp is a...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFAU9Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Icosapent Ethyl 1 Gram Capsule (120-count packages) with a ceiling value of $1,779.42. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract calls for performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, with an ultimate completion date of August 1, 2025. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026 that enables the company to supply comprehensive pharmaceutical and medical products to support military healthcare operations globally. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical federal medical procurement vendor for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates capability across diverse therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. As a prime vendor to the DLA Medical Supply Chain, AmerisourceBergen supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The company's consistent receipt of competitively awarded delivery orders ranging from minimal to substantial values reflects its established capacity to meet federal pharmaceutical procurement requirements through the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 7/31/25 |